Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE
    • بيانات النشر:
      Publication: Oxford : Oxford University Press
      Original Publication: London.
    • الموضوع:
    • نبذة مختصرة :
      Leucine-rich glioma-inactivated 1 (LGI1) is a secreted neuronal protein that forms a trans-synaptic complex that includes the presynaptic disintegrin and metalloproteinase domain-containing protein 23 (ADAM23), which interacts with voltage-gated potassium channels Kv1.1, and the postsynaptic ADAM22, which interacts with AMPA receptors. Human autoantibodies against LGI1 associate with a form of autoimmune limbic encephalitis characterized by severe but treatable memory impairment and frequent faciobrachial dystonic seizures. Although there is evidence that this disease is immune-mediated, the underlying LGI1 antibody-mediated mechanisms are unknown. Here, we used patient-derived immunoglobulin G (IgG) antibodies to determine the main epitope regions of LGI1 and whether the antibodies disrupt the interaction of LGI1 with ADAM23 and ADAM22. In addition, we assessed the effects of patient-derived antibodies on Kv1.1, AMPA receptors, and memory in a mouse model based on cerebroventricular transfer of patient-derived IgG. We found that IgG from all patients (n = 25), but not from healthy participants (n = 20), prevented the binding of LGI1 to ADAM23 and ADAM22. Using full-length LGI1, LGI3, and LGI1 constructs containing the LRR1 domain (EPTP1-deleted) or EPTP1 domain (LRR3-EPTP1), IgG from all patients reacted with epitope regions contained in the LRR1 and EPTP1 domains. Confocal analysis of hippocampal slices of mice infused with pooled IgG from eight patients, but not pooled IgG from controls, showed a decrease of total and synaptic levels of Kv1.1 and AMPA receptors. The effects on Kv1.1 preceded those involving the AMPA receptors. In acute slice preparations of hippocampus, patch-clamp analysis from dentate gyrus granule cells and CA1 pyramidal neurons showed neuronal hyperexcitability with increased glutamatergic transmission, higher presynaptic release probability, and reduced synaptic failure rate upon minimal stimulation, all likely caused by the decreased expression of Kv1.1. Analysis of synaptic plasticity by recording field potentials in the CA1 region of the hippocampus showed a severe impairment of long-term potentiation. This defect in synaptic plasticity was independent from Kv1 blockade and was possibly mediated by ineffective recruitment of postsynaptic AMPA receptors. In parallel with these findings, mice infused with patient-derived IgG showed severe memory deficits in the novel object recognition test that progressively improved after stopping the infusion of patient-derived IgG. Different from genetic models of LGI1 deficiency, we did not observe aberrant dendritic sprouting or defective synaptic pruning as potential cause of the symptoms. Overall, these findings demonstrate that patient-derived IgG disrupt presynaptic and postsynaptic LGI1 signalling, causing neuronal hyperexcitability, decreased plasticity, and reversible memory deficits.
    • Comments:
      Comment in: Brain. 2018 Nov 1;141(11):3092-3095. (PMID: 30364979)
    • References:
      Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7719-7724. (PMID: 28673977)
      Neurology. 2016 Jun 14;86(24):2235-42. (PMID: 27170573)
      Neurology. 2016 Aug 23;87(8):759-65. (PMID: 27466467)
      Neuron. 2000 Dec;28(3):927-39. (PMID: 11163277)
      Brain. 2013 Oct;136(Pt 10):3151-62. (PMID: 24014519)
      Brain. 2015 Jan;138(Pt 1):94-109. (PMID: 25392198)
      Ann Neurol. 2017 Feb;81(2):183-192. (PMID: 28026029)
      Epilepsia. 2011 Jan;52(1):121-31. (PMID: 21054347)
      Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4129-37. (PMID: 26178195)
      Hum Mol Genet. 2002 May 1;11(9):1119-28. (PMID: 11978770)
      Mol Cell Neurosci. 2009 Dec;42(4):448-57. (PMID: 19796686)
      Science. 2006 Sep 22;313(5794):1792-5. (PMID: 16990550)
      Ann Neurol. 2017 Feb;81(2):193-198. (PMID: 28026046)
      Neurology. 2016 Oct 4;87(14):1449-1456. (PMID: 27590293)
      Physiol Rev. 2017 Apr;97(2):839-887. (PMID: 28298428)
      Nat Rev Neurol. 2017 May;13(5):290-301. (PMID: 28418022)
      Neuron. 1995 Apr;14(4):795-802. (PMID: 7718241)
      J Physiol. 2010 Jan 1;588(Pt 1):107-16. (PMID: 19933758)
      J Neurosci. 2013 Nov 13;33(46):18161-74. (PMID: 24227725)
      Elife. 2017 Nov 14;6:. (PMID: 29135436)
      Brain. 2010 Sep;133(9):2734-48. (PMID: 20663977)
      Cell Rep. 2018 Jun 26;23(13):3759-3768. (PMID: 29949761)
      Neuron. 2018 Oct 10;100(1):91-105.e9. (PMID: 30146304)
      Brain. 2010 Sep;133(9):2749-62. (PMID: 20659958)
      Sci Rep. 2016 Feb 16;6:21769. (PMID: 26878798)
      Nat Med. 2009 Oct;15(10):1208-14. (PMID: 19701204)
      Ann Neurol. 1999 Feb;45(2):182-8. (PMID: 9989620)
      Neuron. 2006 Mar 2;49(5):697-706. (PMID: 16504945)
      N Engl J Med. 2018 Mar 1;378(9):840-851. (PMID: 29490181)
      Br J Pharmacol. 2007 Mar;150(6):758-65. (PMID: 17279087)
      Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3799-804. (PMID: 20133599)
      Brain. 2010 Nov;133(11):3166-80. (PMID: 20884644)
      Hum Mol Genet. 2010 May 1;19(9):1702-11. (PMID: 20130004)
      Brain. 2012 May;135(Pt 5):1606-21. (PMID: 22544902)
      Hum Mol Genet. 2006 Dec 1;15(23):3436-45. (PMID: 17067999)
      Ann Neurol. 2016 Sep;80(3):388-400. (PMID: 27399303)
      Ann Neurol. 2017 Jul;82(1):79-92. (PMID: 28628235)
      Front Neurol. 2015 Jun 11;6:136. (PMID: 26124746)
      Lancet Neurol. 2010 Aug;9(8):776-85. (PMID: 20580615)
      PLoS Biol. 2010 Jun 29;8(6):e1000412. (PMID: 20613859)
      Trends Biochem Sci. 2002 Sep;27(9):441-4. (PMID: 12217514)
    • Grant Information:
      R01 NS077851 United States NS NINDS NIH HHS
    • الرقم المعرف:
      0 (Disks Large Homolog 4 Protein)
      0 (Immunoglobulin G)
      0 (Intracellular Signaling Peptides and Proteins)
      0 (LGI1 protein, human)
      0 (Nerve Tissue Proteins)
      0 (Proteins)
      0 (Receptors, AMPA)
      147173-20-4 (Kv1.1 Potassium Channel)
      EC 3.4.24.- (ADAM Proteins)
      EC 3.4.24.- (ADAM22 protein, human)
      EC 3.4.24.- (ADAM23 protein, human)
    • الموضوع:
      Autoimmune limbic encephalitis
    • الموضوع:
      Date Created: 20181023 Date Completed: 20190715 Latest Revision: 20240207
    • الموضوع:
      20240207
    • الرقم المعرف:
      PMC6202570
    • الرقم المعرف:
      10.1093/brain/awy253
    • الرقم المعرف:
      30346486